Zobrazeno 1 - 10 of 346 pro vyhledávání: '"DA Revicki"'
4
Validation of the revised Patient Perception of Migraine Questionnaire (PPMQ-R): measuring satisfaction with acute migraine treatment in clinical trials
Autor: M Kimel, DA Revicki, J McCormack, SP Burch, R Hsieh
Publikováno v: Cephalalgia : an international journal of headache. 28(5)
This study was aimed to evaluate in clinical trial settings the psychometric properties of the revised Patient Perception of Migraine Questionnaire (PPMQR), a satisfaction measure for acute migraine treatment. The PPMQ-R was administered 24 h post do
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cefa2dea197e86d0d548f274a3919e62
https://pubmed.ncbi.nlm.nih.gov/18384420
Zobrazit plný text záznamu
5
Specific occupational satisfaction and stresses that differentiate paid and volunteer EMTs
Autor: Theodore W. Whitley, Sandra S. Landis, E.J. Allison, DA Revicki
Publikováno v: Annals of emergency medicine. 16(6)
A survey completed by 265 emergency medical technicians (EMTs) who provide emergency prehospital care in a rural area included a stress inventory for health professionals and a job satisfaction scale. Logistic regression indicated that the 118 paid E
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8946788fdeababfd75efc9ef14dcf980
https://pubmed.ncbi.nlm.nih.gov/3495210
Zobrazit plný text záznamu
7
Akademický článek
United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument.
Autor: King MT; School of Psychology, Faculty of Science, University of Sydney, Sydney, NSW, Australia. madeleine.king@sydney.edu.au., Revicki DA; Revicki Outcomes Research Consulting, Sarasota, FL, USA., Norman R; School of Population Health, Curtin University, Perth, WA, Australia., Müller F; Medical Psychology, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands., Viney RC; Centre for Health Economics Research & Evaluation, Faculty of Health, University of Technology Sydney, Sydney, NSW, Australia., Pickard AS; Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA., Cella D; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Shaw JW; Patient-Reported Outcomes Assessment, Global Health Economics and Outcomes Research, Bristol Myers Squibb, Lawrenceville, NJ, USA.
Publikováno v: PharmacoEconomics - open [Pharmacoecon Open] 2024 Jan; Vol. 8 (1), pp. 49-63. Date of Electronic Publication: 2023 Dec 07.
Zobrazit plný text záznamu
8
Akademický článek
Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care.
Autor: Tomlinson B; Seidman Cancer Center, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio. Electronic address: Benjamin.Tomlinson@UHhospitals.org., de Lima M; Department of Hematology, Ohio State University, Columbus, Ohio., Cogle CR; Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, Florida., Thompson MA; Aurora Research Institute, Advocate Aurora Health, Milwaukee, Wisconsin., Grinblatt DL; NorthShore Medical Group, NorthShore University Health System, Evanston, Illinois., Pollyea DA; University of Colorado Cancer Center, Aurora, Colorado., Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida., Roboz GJ; Weill Cornell College of Medicine and New York-Presbyterian Hospital, New York, New York., Savona MR; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Abedi M; University of California Davis, Comprehensive Cancer Center, Sacramento, California., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas., Kurtin SE; University of Arizona Cancer Center, Tucson, Arizona., Maciejewski JP; Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida., Patel JL; Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, Utah., Revicki DA; Outcomes Research Consulting, Sarasota, Florida., George TI; Department of Pathology, University of Utah and ARUP Laboratories, Salt Lake City, Utah., Flick ED; Bristol Myers Squibb, Princeton, New Jersey., Kiselev P; Bristol Myers Squibb, Princeton, New Jersey., Louis CU; Bristol Myers Squibb, Princeton, New Jersey., DeGutis IS; Bristol Myers Squibb, Princeton, New Jersey., Nifenecker M; Bristol Myers Squibb, Princeton, New Jersey., Erba HP; Duke Cancer Institute, North Carolina., Steensma DP; Dana-Farber Cancer Institute, Boston, Massachusetts., Scott BL; Fred Hutchinson Cancer Research Center, Seattle, Washington.
Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2023 Jul; Vol. 29 (7), pp. 460.e1-460.e9. Date of Electronic Publication: 2023 Apr 21.
Zobrazit plný text záznamu
9
Akademický článek
Identifying symptomatic adverse events using the patient-reported outcomes version of the common terminology criteria for adverse events in patients with non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations.
Autor: Zhu Y; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of TakedaPharmaceutical Company Limited, Massachusetts, Cambridge, USA., Jean-Baptiste M; Evidera Inc., Bethesda, Maryland, USA., Lenderking WR; Evidera Inc., Bethesda, Maryland, USA.; Evidera Inc., Waltham, Massachusetts, USA., Bell JA; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of TakedaPharmaceutical Company Limited, Massachusetts, Cambridge, USA., Revicki DA; Evidera Inc., Bethesda, Maryland, USA., Lin HM; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of TakedaPharmaceutical Company Limited, Massachusetts, Cambridge, USA., Brake R; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of TakedaPharmaceutical Company Limited, Massachusetts, Cambridge, USA., Reeve BB; Duke University School of Medicine, Durham, North Carolina, USA.
Publikováno v: Cancer medicine [Cancer Med] 2023 Mar; Vol. 12 (5), pp. 5494-5505. Date of Electronic Publication: 2022 Dec 30.
Zobrazit plný text záznamu
10
Akademický článek
Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials.
Autor: Lipton RB; Albert Einstein College of Medicine, Bronx, NY, USA., Singh RBH; Mayo Clinic, Phoenix, AZ, USA., Revicki DA; Outcomes Research Consulting, Sarasota, FL, USA., Zhao S; AbbVie, Madison, NJ, USA., Shewale AR; AbbVie, 2525 Dupont Dr., Irvine, CA, 92612, USA. anand.shewale@abbvie.com., Lateiner JE; AbbVie, 2525 Dupont Dr., Irvine, CA, 92612, USA., Dodick DW; Mayo Clinic, Phoenix, AZ, USA.
Publikováno v: The journal of headache and pain [J Headache Pain] 2022 Apr 25; Vol. 23 (1), pp. 50. Date of Electronic Publication: 2022 Apr 25.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje